The Molecule Republic: India’s Pharmaceutical Renaissance Beyond 2040
A Strategic Narrative on Sovereignty, Science, and the Ethics of Scale When historians of industry write about India beyond 2040, they may not describe it merely as the “pharmacy of the world.” That phrase, powerful in its time, captured a phase — an era defined by generics, vaccines, cost leadership, and supply resilience. But the decades after 2040 will demand…
